Table 1.
SNP ID | MAF | Gene Name | CHR | Gene function | Type of reference study |
Sample size reference study |
χ2 statistic reference study |
OR reference study |
N of parent- child trios after quality control in present study |
Power in present studyb |
Reference |
---|---|---|---|---|---|---|---|---|---|---|---|
Implicated in TS | |||||||||||
| |||||||||||
rs1800497 | 0.18 | ANKK1/DRD2 | 11 | Serine / Threonine kinase | Case-control | 147 TS / 314 controls | 19.4 | 179 | [3] | ||
rs9357271c | 0.24 | BTBD9 | 6 | Protein-protein interactions | Case-control | 322 TS / 290 controls | 8.02 | 371 | [32] | ||
rs11264126 | 0.49 | DLGAP3 | 1 | Post-synaptic scaffolding protein | TDT | 289 parent-child trios | 1.41 | 371 | 0.91 | [33] | |
rs12141243 | 0.11 | DLGAP3 | 1 | Post-synaptic scaffolding protein | TDT | 289 parent-child trios | 1.04 | 179 | <0.10 | [33] | |
rs6279 | 0.31 | DRD2 | 11 | Dopamine receptor | TDT | 69 parent-child trios | 11.5 | 179 | [34] | ||
rs1079597 | 0.11 | DRD2 | 11 | Dopamine receptor | TDT | 69 parent-child trios | 11.5 | 371 | [34] | ||
rs4648318 | 0.25 | DRD2 | 11 | Dopamine receptor | TDT | 69 parent-child trios | 11.5 | 371 | [34] | ||
rs854150 | 0.36 | HDC | 15 | Histamine synthesis | TDT | 520 TS families | 8.13 | 179 | [35] | ||
rs518147 | 0.37 | HTR2C | X | Serotonin receptor | Case-control | 87 TS / 311 controls | 2.50 | 179 | 0.99 | [36] | |
rs3813929 | 0.18 | HTR2C | X | Serotonin receptor | Case-control | 87 TS / 311 controls | 1.89 | 371 | 0.99 | [36] | |
rs6347 | 0.24 | SLC6A3/DAT1 | 5 | Dopamine transporter | Case-control | 266 cases / 236 controls | 8.40 | 1.78f | 179 | 0.92 | [37] |
rs9593835g | 0.26 | SLITRK1 | 13 | Neurite outgrowth | TDT | 154 TS families | 6.22 | 1.66h | 371 | 0.99 | [38] |
rs9531520 | 0.19 | SLITRK1 | 13 | Neurite outgrowth | TDT | 154 TS families | 6.22 | 1.45h | 179 | 0.55 | [38] |
rs3744161 | 0.46 | TBCD | 17 | Tubulin folding protein | TDT | 100 TS families | 179 | [39] | |||
rs662669 | 0.42 | TBCD | 17 | Tubulin folding protein | TDT | 100 TS families | 179 | [39] | |||
rs4565946 | 0.49 | TPH2 | 12 | Serotonin synthesis | Case-control | 98 TS / 178 controls | 1.95 / 1.65k | 371 | 0.99 / 0.99k | [31] | |
rs4570625 | 0.2 | TPH2 | 12 | Serotonin synthesis | Case-control | 98 TS / 178 controls | 1.95 / 1.65k | 371 | 0.99 / 0.98k | [31] | |
| |||||||||||
Implicated in related disorders | |||||||||||
| |||||||||||
rs4680 | 0.47 | COMT | 22 | Dopamine degradation | Meta-analysis | 47,358 cases OCD/ 68,942 controls / 2433 OCD parent-child trios | 371 | [40] | |||
rs7794745 | 0.31 | CNTNAP2 | 7 | Cell adhesion molecule | TDT | 145 autism parent-child trios and 78 sib-pairs | 371 | [41] |
TS, Tourette syndrome; OCD, obsessive-compulsive disorder; ASD, autism spectrum disorder; MAF, minor allele frequency (based on the HapMap-CEU population); CHR, chromosome; OR, odds ratio; ANKK1, Ankyrin Repeat And Kinase Domain Containing 1; DRD2, dopamine receptor D2; BTBD9, BTB (POZ) Domain Containing 9; CNTNAP2, Contactin Associated Protein-Like 2; DLGAP3, Discs, Large (Drosophila) Homolog-Associated Protein 3; TDT, transmission disequilibrium test; HDC, l-histidine decarboxylase; 5-HT receptor 2C; SLC6A3, solute carrier family 6, dopamine transporter; DAT1, Dopamine Transporter 1; SLITRK1, SLIT And NTRK-Like Family, Member 1; TBCD, Tubulin Folding Cofactor; TPH2, tryptophan hydroxylase 2; COMT, Catechol-O-Methyltransferase.
All SNPs passed standard quality control checks in PLINK V1.07 using the recommended parameters published in [29, 30].
When the reference study had provided an odds ratio, we calculated the power in the present study, based on the number of available parent-child trios for each SNP (Table S2), the reported minor allele frequency, odds ratio in the reference study, and α=0.05 (see also Table S3).
This SNP is in high LD (R2>0.8) with the implicated SNPs rs4714156 and rs9296249.
rs11264126 was nominally significant and together with rs12141243 nominally significant in two haplotypes.
Results reported for the haplotype analysis of the reference study.
Odds ratio reported for the genotypic comparison of the AG versus the AA genotype.
This SNP is in high LD (R2>0.8) with the implicated SNP rs9546538.
Odds ratios were obtained from the single marker analysis.
The results of the single marker analysis followed by the results of haplotype analysis (the haplotype that contains SNPs rs9593835, rs9531520, and rs9546538).
Results reported for multiple families.
Results reported of the haplotype-based analysis of two haplotypes containing rs4565946 and rs457062.
Based on a meta-analysis of 25 datasets.